Yuqiong Xu

Title: Yuqiong Xu: Innovator in EGFR Inhibition

Introduction

Yuqiong Xu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target specific biological pathways.

Latest Patents

Yuqiong Xu holds a patent for the "Use of pteridinone derivative serving as EGFR inhibitor." This invention relates to a pteridinone derivative that acts as an EGFR inhibitor, which is crucial for treating diseases mediated by the epidermal growth factor receptor (EGFR). The patent details a compound represented by a specific formula, along with pharmaceutical compositions that include this compound. The invention aims to provide effective treatments for EGFR-mediated diseases.

Career Highlights

Yuqiong Xu is affiliated with the East China University of Science and Technology, where he engages in research and development activities. His work focuses on innovative solutions in the pharmaceutical industry, contributing to advancements in drug development.

Collaborations

Yuqiong Xu collaborates with notable colleagues, including Honglin Li and Yufang Xu. Their combined expertise enhances the research output and innovation potential within their field.

Conclusion

Yuqiong Xu's work in developing EGFR inhibitors showcases his commitment to advancing medical science. His contributions are vital for the ongoing efforts to create effective treatments for serious health conditions.